Latest Cervarix Stories
PHILADELPHIA, Oct. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S.
GlaxoSmithKline announced today that the US Food and Drug Administration has approved CERVARIX for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus types 16 and 18 for use in girls and young women (aged 10-25).
Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.
Cervical cancer prevention efforts should prioritize vaccinating pre-adolescent girls and continued cervical cancer screening.
Health authorities are working alongside British drug giant GlaxoSmithKline in an effort to investigate the death of a schoolgirl following a cervical cancer vaccination.
A 14-year-old girl British girl died and several others were hospitalized after being vaccinated against the human papilloma virus, officials said. Natalie Morton died Monday after being vaccinated with Cervarix at her school in Coventry, The Times of London reported Tuesday. Several classmates were hospitalized the same day with side effects from Cervarix, a vaccine that protects against cervical cancer, The Times reported. Morton's is the first death in a national campaign that has...
A federal report released Thursday showed that one in three teenage girls have gotten a cervical cancer vaccine, but vaccination rates vary dramatically between states.
WINSTON-SALEM, N.C., Sept.
Cervical cancer vaccines have gotten quite a boost since a United States advisory panel recommended the approval of GlaxoSmithKline's Cervarix, which is expected to give Merck & Co's Gardasil a run for its money.
- The governor of a province or people.